https://orcid.org/0000-0001-5979-7868
References
- Almutawa F, Alnomair N, Wang Y, Hamzavi I, Lim HW. Systematic review of UV-based therapy for psoriasis. Am J Clin Dermatol. 2013;14(2):87–109. doi:10.1007/s40257-013-0015-y
- Newton L, DeLozier AM, Griffiths PC, et al. Exploring content and psychometric validity of newly developed assessment tools for itch and skin pain in atopic dermatitis. J Patient Rep Outcomes. 2019;3(1):42. doi:10.1186/s41687-019-0128-z
- Swerlick RA, Zhang C, Patel A, Chren MM, Chen S. The Skindex-Mini: a streamlined quality of life measurement tool suitable for routine use in clinic. J Am Acad Dermatol. 2021;85(2):510–512. doi:10.1016/j.jaad.2018.12.035
- Koek MB, Buskens E, van Weelden H, Steegmans PH, Bruijnzeel-Koomen CA, Sigurdsson V. Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (Pluto study). BMJ. 2009;338:b1542. doi:10.1136/bmj.b1542
- Click J, Alabaster A, Postlethwaite D, Lide W. Effect of availability of at-home phototherapy on the use of systemic medications for psoriasis. Photodermatol Photoimmunol Photomed. 2017;33(6):345–346. doi:10.1111/phpp.12349
- Yentzer BA, Feldman SR. Trends in home phototherapy adoption in the US: monetary disincentives are only the tip of the iceberg. J Dermatolog Treat. 2011;22(1):27–30. doi:10.3109/09546630903440080
- Hyde K, Cardwell L, Stotts R, Feldman SR. Psoriasis treatment cost comparison: biologics versus home phototherapy. Am J Pharm Benefits. 2018;10(1):18–21.